Tuning a 96-Well Microtiter Plate Fluorescence-Based Assay to Identify AGE Inhibitors in Crude Plant Extracts
暂无分享,去创建一个
Pascal Richomme | Sylvie Morel | Séverine Derbré | L. Sanguinet | P. Richomme | S. Derbré | Denis Séraphin | Luc Séro | Lionel Sanguinet | Patricia Blanchard | Bach Tai Dang | L. Séro | D. Séraphin | Sylvie Morel | P. Blanchard
[1] S. Rahbar,et al. Novel inhibitors of advanced glycation endproducts. , 2003, Biochemical and biophysical research communications.
[2] D. Appleton,et al. Rapid isolation of geraniin from Nephelium lappaceum rind waste and its anti-hyperglycemic activity , 2011 .
[3] Xiaohua Douglas Zhang. A pair of new statistical parameters for quality control in RNA interference high-throughput screening assays. , 2007, Genomics.
[4] M. Litaudon,et al. Bioguided fractionation and isolation of natural inhibitors of advanced glycation end-products (AGEs) from Calophyllum flavoramulum. , 2012, Phytochemistry.
[5] S. S. Samra,et al. Accelerated atherosclerosis. , 2002, Journal of the Indian Medical Association.
[6] D. Newman,et al. Natural products as sources of new drugs over the last 25 years. , 2007, Journal of natural products.
[7] S. Genuth,et al. Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Contro , 1999, Diabetes.
[8] J. Cornard,et al. Protic equilibria as the key factor of quercetin emission in solution. Relevance to biochemical and analytical studies. , 2011, Physical chemistry chemical physics : PCCP.
[9] J. Gatto,et al. Automating a 96-well microtiter plate assay for identification of AGEs inhibitors or inducers: application to the screening of a small natural compounds library , 2010, Analytical and bioanalytical chemistry.
[10] M. Sternberg,et al. Advanced glycation endproducts (AGEs): Pharmacological inhibition in diabetes. , 2006, Pathologie-biologie.
[11] D. Vashishth. Advanced Glycation End-products and Bone Fractures. , 2009, IBMS boneKEy.
[12] M. Ubukata,et al. Screening System for the Maillard Reaction Inhibitor from Natural Product Extracts , 2002 .
[13] Feng Chen,et al. Naturally occurring inhibitors against the formation of advanced glycation end-products. , 2011, Food & function.
[14] Merlin C. Thomas,et al. Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis. , 2004, Diabetes.
[15] K. Bark,et al. Spectroscopic Studies on the Oxidation of Catechin in Aqueous Solution , 2011 .
[16] K Kawanishi,et al. Inhibitors of aldose reductase and advanced glycation end-products formation from the leaves of Stelechocarpus cauliflorus R.E. Fr. , 2007, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[17] Jan van der Greef,et al. Quality and safety of Chinese herbal medicines guided by a systems biology perspective. , 2009, Journal of ethnopharmacology.
[18] A. Meyers,et al. Chiral formamidines. The total asymmetric synthesis of (-)-8-azaestrone and related (-)-8-aza-12-oxo-17-desoxoestrone , 1992 .
[19] V. Monnier,et al. Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. , 1989, The Journal of biological chemistry.
[20] Xiaohua Douglas Zhang,et al. Novel Analytic Criteria and Effective Plate Designs for Quality Control in Genome-Scale RNAi Screens , 2008, Journal of biomolecular screening.
[21] J. DeGroot. The AGE of the matrix: chemistry, consequence and cure. , 2004, Current opinion in pharmacology.
[22] S. Rahbar,et al. Novel inhibitors of advanced glycation endproducts (part II). , 2000, Molecular cell biology research communications : MCBRC.
[23] F. Hayase,et al. Formation and determination of α-dicarbonyls and an AGE cross-link, pyrropyridine in glycated proteins and in vivo , 2002 .
[24] H. Corstjens,et al. Two fluorescent wavelengths, 440(ex)/520(em) nm and 370(ex)/440(em) nm, reflect advanced glycation and oxidation end products in human skin without diabetes. , 2012, Diabetes technology & therapeutics.
[25] G. Yen,et al. Inhibition of advanced glycation endproduct formation by foodstuffs. , 2011, Food & function.
[26] R. Nagai,et al. Astragalosides isolated from the root of astragalus radix inhibit the formation of advanced glycation end products. , 2009, Journal of agricultural and food chemistry.
[27] A. Ardestani,et al. Inhibitory effects of ethyl acetate extract of Teucrium polium on in vitro protein glycoxidation. , 2007, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[28] M. Díaz,et al. Solvent effect on the UV/Vis absorption and fluorescence spectroscopic properties of berberine , 2009, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[29] S. Pongor,et al. Aging of proteins: isolation and identification of a fluorescent chromophore from the reaction of polypeptides with glucose. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[30] R. Khalifah,et al. Amadorins: novel post-Amadori inhibitors of advanced glycation reactions. , 1999, Biochemical and biophysical research communications.
[31] V. Monnier,et al. Intervention against the Maillard reaction in vivo. , 2003, Archives of biochemistry and biophysics.
[32] T. Gürkan. Fluorimetric analysis of alkaloids. Determination of serpentine, yohimbine, and boldine , 1976, Mikrochimica acta.
[33] D. W. Fink,et al. pH Effects on fluorescence of umbelliferone , 1970 .
[34] V. Basevi,et al. Standards of Medical Care in Diabetes—2012 , 2011, Diabetes Care.
[35] S. Bennett,et al. Inhibition of Advanced Glycation End Product Formation by Medicinal Plant Extracts Correlates with Phenolic Metabolites and Antioxidant Activity , 2010, Planta medica.
[36] J. Vinson,et al. Inhibition of protein glycation and advanced glycation end products by ascorbic acid and other vitamins and nutrients , 1996 .
[37] T. Yanagisawa,et al. High-performance liquid chromatographic assay with fluorescence detection for the determination of cephaeline and emetine in human plasma and urine. , 2001, Journal of chromatography. B, Biomedical sciences and applications.
[38] C. Lii,et al. Relationship between antioxidant and antiglycation ability of saponins, polyphenols, and polysaccharides in Chinese herbal medicines used to treat diabetes , 2011 .
[39] J. Kennedy,et al. Pharmacognosy, Phytochemistry, Medicinal Plants (2nd ed.) , 2000 .
[40] I. C. Walker,et al. The electronic states of the azines. II. Pyridine, studied by VUV absorption, near-threshold electron energy loss spectroscopy and ab initio multi-reference configuration interaction calculations , 1990 .
[41] L. Maillard,et al. Action des acides amines sur les sucres : formation des melanoidines par voie methodique , 1912 .
[42] Z. Cerovic,et al. Time-resolved spectral studies of blue-green fluorescence of artichoke (Cynara cardunculus L. Var. Scolymus) leaves: identification of chlorogenic acid as one of the major fluorophores and age-mediated changes. , 2005, Journal of agricultural and food chemistry.
[43] A. Upadhyay,et al. Advanced glycation end products inhibitors from Alpinia zerumbet rhizomes. , 2011, Food chemistry.
[44] David J Newman,et al. Natural products as sources of new drugs over the 30 years from 1981 to 2010. , 2012, Journal of natural products.
[45] T. Metz,et al. Chelation: A Fundamental Mechanism of Action of AGE Inhibitors, AGE Breakers, and Other Inhibitors of Diabetes Complications , 2012, Diabetes.
[46] A. Barden,et al. Advanced Glycation End Products: A Review , 2013 .
[47] R. Nagaraj,et al. Protein modification by methylglyoxal: chemical nature and synthetic mechanism of a major fluorescent adduct. , 1997, Archives of biochemistry and biophysics.
[48] K Nakamura,et al. Acid-stable fluorescent advanced glycation end products: vesperlysines A, B, and C are formed as crosslinked products in the Maillard reaction between lysine or proteins with glucose. , 1997, Biochemical and biophysical research communications.
[49] J. Choi,et al. Antidiabetic complications and anti‐alzheimer activities of sophoflavescenol, a prenylated flavonol from Sophora flavescens, and its structure–activity relationship , 2011, Phytotherapy research : PTR.
[50] K. Yamagata,et al. Immunochemical detection of Nepsilon-(carboxyethyl)lysine using a specific antibody. , 2008, Journal of immunological methods.
[51] R. Haugland. Handbook of fluorescent probes and research products , 2002 .
[52] Gwendal Latouche,et al. In vivo localization at the cellular level of stilbene fluorescence induced by Plasmopara viticola in grapevine leaves , 2012, Journal of Experimental Botany.
[53] Pgce CBiol Honorary Senior Fellow C Day PhD,et al. Metformin: its botanical background , 2004 .
[54] V. P. Reddy,et al. Inhibitors of the Maillard reaction and AGE breakers as therapeutics for multiple diseases. , 2006, Drug discovery today.
[55] S. Yamagishi,et al. Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease. , 2008, Current pharmaceutical design.
[56] G. Rusak,et al. Phenolic content and antioxidative capacity of green and white tea extracts depending on extraction conditions and the solvent used. , 2008, Food chemistry.
[57] M. Florêncio,et al. Towards the control and inhibition of glycation-the role of the guanidine reaction center with aldehydic and diketonic dicarbonyls. A mass spectrometry study. , 2006, Journal of mass spectrometry : JMS.
[58] M. Saleemuddin,et al. A procedure for the rapid screening of Maillard reaction inhibitors. , 2008, Journal of biochemical and biophysical methods.
[59] M. Grillo,et al. Advanced glycation end-products (AGEs): involvement in aging and in neurodegenerative diseases , 2008, Amino Acids.
[60] Y. Jang,et al. Standards of Medical Care in Diabetes-2010 by the American Diabetes Association: Prevention and Management of Cardiovascular Disease , 2010 .
[61] R. Bucala,et al. Long-term assessment of glucose control by haemoglobin-AGE measurement , 1996, The Lancet.
[62] Alan W. Stitt. The Maillard Reaction in Eye Diseases , 2005, Annals of the New York Academy of Sciences.
[63] M. Brownlee. Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.
[64] M. Litaudon,et al. Preparative isolation, fast centrifugal partition chromatography purification and biological activity of cajaflavanone from Derris ferruginea stems. , 2012, Phytochemical analysis : PCA.
[65] Thomas D. Y. Chung,et al. A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.
[66] T. Haskell,et al. The fluorescent oxidation products of dihydroxyphenylalanine and its esters. , 2000, Journal of photochemistry and photobiology. B, Biology.
[67] S. Takasawa,et al. Receptor for Advanced Glycation End Products Is a Promising Target of Diabetic Nephropathy , 2005, Annals of the New York Academy of Sciences.
[68] N. Clark,et al. Standards of Medical Care in Diabetes: Response to Power , 2006 .